Inhibition of IRAK1 As a Novel Therapeutic Strategy in Acute Myeloid Leukemia and Myelodysplastic Syndrome

被引：0
|
作者：
Rhyasen, Garrett [1 ]
Bolanos, Lyndsey [1 ]
Fang, Jing [1 ]
Rigolino, Carmen [2 ]
Cortelezzi, Agostino [3 ,4 ]
Oliva, Esther Natalie [5 ]
Cuzzola, Mariella [2 ]
Starczynowski, Daniel T. [1 ]
机构：
[1] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA
[2] Azienda Osped, Bone Marrow Transplant Unit, Reggio Di Calabria, Italy
[3] IRCCS Fdn Ca Granda, Milan, Italy
[4] Univ Milan, Milan, Italy
[5] Azienda Osped BMM, Hematol Unit, Reggio Di Calabria, Italy
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [1] Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
    Rhyasen, Garrett W.
    Bolanos, Lyndsey
    Fang, Jing
    Jerez, Andres
    Wunderlich, Mark
    Rigolino, Carmela
    Mathews, Lesley
    Ferrer, Marc
    Southall, Noel
    Guha, Rajarshi
    Keller, Jonathan
    Thomas, Craig
    Beverly, Levi J.
    Cortelezzi, Agostino
    Oliva, Esther N.
    Cuzzola, Maria
    Maciejewski, Jaroslaw P.
    Mulloy, James C.
    Starczynowski, Daniel T.
    CANCER CELL, 2013, 24 (01) : 90 - 104
  • [2] PAK1 Is a Therapeutic Target in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Stanley, Robert
    Pandolfi, Ashley
    Verma, Amit
    Steidl, Ulrich
    Chernoff, Jonathan
    Yu, Yiting
    Boultwood, Jacqueline
    BLOOD, 2014, 124 (21)
  • [3] PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
    Pandolfi, Ashley
    Stanley, Robert F.
    Yu, Yiting
    Bartholdy, Boris
    Pendurti, Gopichand
    Gritsman, Kira
    Boultwood, Jacqueline
    Chernoff, Jonathan
    Verma, Amit
    Steidl, Ulrich
    BLOOD, 2015, 126 (09) : 1118 - 1127
  • [4] PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
    Kontandreopoulou, Christina-Nefeli
    Diamantopoulos, Panagiotis T.
    Tiblalexi, Despina
    Giannakopoulou, Nefeli
    Viniou, Nora-Athina
    BLOOD ADVANCES, 2021, 5 (22) : 4794 - 4805
  • [5] Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies
    Li, Zhaoyang
    Younger, Kenisha
    Gartenhaus, Ronald
    Joseph, Ann Mary
    Hu, Fang
    Baer, Maria R.
    Brown, Patrick
    Davila, Eduardo
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (03): : 1081 - 1097
  • [6] Pacritinib Targets IRAK1 and Shows Synergy with HDAC and BET Inhibitors in Acute Myeloid Leukemia
    Puri, Alka
    Mahmood, Shawn
    Maertens, Bernadette
    Davare, Monika
    Kurtz, Stephen E.
    Tognon, Cristina E.
    Eden, Christopher O.
    Elferich, Johannes
    Shinde, Ujwal
    Druker, Brian J.
    Singer, Jack W.
    Agarwal, Anupriya
    BLOOD, 2016, 128 (22)
  • [7] Inhibition Of LSD1 As a Therapeutic Strategy For The Treatment Of Acute Myeloid Leukemia
    Kruger, Ryan G.
    Mohammad, Helai
    Smitheman, Kimberly
    Cusan, Monica
    Liu, Yan
    Pappalardi, Melissa
    Federowicz, Kelly
    Van Aller, Glenn
    Kasparec, Jiri
    Tian, Xinrong
    Suarez, Dominic
    Rouse, Meagan
    Schneck, Jessica
    Carson, Jeffrey
    McDevitt, Patrick
    Ho, Thau
    McHugh, Charles
    Miller, William
    Johnson, Neil
    Armstrong, Scott A.
    Tummino, Peter
    BLOOD, 2013, 122 (21) : 3964 - 3867
  • [8] INHIBITION OF THE MYELOID MASTER REGULATOR PU.1 AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA
    Antony-Debre, Ileana
    Leite, Joana
    Paul, Ananya
    Mitchell, Kelly
    Kim, Hye Mi
    Huang, Kenneth
    Kumar, Arvind
    Farahat, Abdelbasset A.
    Bartholdy, Boris
    Narayanagari, Swathi-Rao
    Carvajal, Luis A.
    Chen, Jiahao
    Ambesi-Impiombato, Alberto
    Ferrando, Adolfo A.
    Mantzaris, Ioannis
    Gavathiotis, Evripidis
    Verma, Amit
    Will, Britta
    Boykin, David W.
    Wilson, W. David
    Poon, Gregory M. K.
    Steidl, Ulrich
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : S133 - S133
  • [9] INHIBITION OF THE MYELOID MASTER REGULATOR PU.1 AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA
    Antony-Debre, I.
    Leite, J.
    Paul, A.
    Mitchell, K.
    Kim, H. M.
    Huang, K.
    Kumar, A.
    Farahat, A. A.
    Bartholdy, B.
    Narayanagari, S. -R.
    Carvajal, L. A.
    Chen, J.
    Ambesi-Impiombato, A.
    Ferrando, A. A.
    Mantzaris, I.
    Gavathiotis, E.
    Verma, A.
    Will, B.
    Boykin, D. W.
    Wilson, W. D.
    Poon, G. M. K.
    Steidl, U.
    HAEMATOLOGICA, 2017, 102 : 18 - 18
  • [10] Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
    Yosuke Tanaka
    Reina Takeda
    Tsuyoshi Fukushima
    Keiko Mikami
    Shun Tsuchiya
    Moe Tamura
    Keito Adachi
    Terumasa Umemoto
    Shuhei Asada
    Naoki Watanabe
    Soji Morishita
    Misa Imai
    Masayoshi Nagata
    Marito Araki
    Hitoshi Takizawa
    Tomofusa Fukuyama
    Chrystelle Lamagna
    Esteban S. Masuda
    Ryoji Ito
    Susumu Goyama
    Norio Komatsu
    Tomoiku Takaku
    Toshio Kitamura
    Nature Communications, 13
12345